Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (HKG:2196)
Hong Kong · Delayed Price · Currency is HKD 23.82
+1.50 (6.72%)
Oct 31, 2025, 4:08 PM HKT
HKG:2196 Market Cap
HKG:2196 has a market cap or net worth of 79.81 billion as of October 31, 2025. Its market cap has increased by 8.89% in one year.
Market Cap
79.81B
Enterprise Value
119.14B
Revenue
43.22B
Ranking
n/a
PE Ratio
22.25
Stock Price
23.82
Market Cap Chart
Since August 9, 2005, HKG:2196's market cap has increased from 4.19B to 79.81B, an increase of 1,802.68%. That is a compound annual growth rate of 15.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 79.85B | 25.58% |
| Dec 31, 2024 | 63.58B | -6.29% |
| Dec 29, 2023 | 67.85B | -30.95% |
| Dec 30, 2022 | 98.27B | -29.69% |
| Dec 31, 2021 | 139.76B | -6.44% |
| Dec 31, 2020 | 149.39B | 105.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 271.02B |
| Hansoh Pharmaceutical Group Company | 209.22B |
| JD Health International | 199.13B |
| WuXi Biologics | 149.43B |
| Innovent Biologics | 144.96B |
| Sino Biopharmaceutical | 125.85B |
| Akeso | 105.01B |
| Sichuan Kelun-Biotech Biopharmaceutical | 98.36B |